Inspection Record

The Pet Apothecary LLC — FDA 483 Findings

US FDAInspected 2018-08-07Published 2019-07-12 8 findingsStability and storageTraining and personnelContamination controlMaterial and supplier controlOther quality systemComplaint and recall handling

View the regulator's official source The source document is always the basis for judgement.

Findings

1Stability and storage

Criteria for Beyond Use Dates (BUDs) assigned to drug formulations produced by your pharmacy are not formally and appropriately established in a written procedure nor supported with cited literature references and/or stability studies.

2Training and personnel

Your pharmacy does not have an established training program for technicians nor do you maintain any training record documentation for on-the-job training that was provided to them.

3Contamination control

Appropriate protective apparel is not always worn by technicians to protect drug products from contamination during production.

4Material and supplier control

Analytical balances, used for weighing drug materials/components, are not uniquely identified nor appropriately calibrated on a periodic basis, nor periodically weight checked with an appropriate certified weight set.

5Material and supplier control

Prescription production records are deficient in that they do not include the following: - name of manufacturers, lot numbers, and expiry dates of all materials/components used.

6Other quality system

Cleaning methods are not established in a written procedure nor are appropriate cleaning agents specified.

7Material and supplier control

Your pharmacy does not have established written procedures or adequate controls in place for receipt and storage of materials/components used to produce drug products.

8Complaint and recall handling

Your pharmacy does not have established written procedures for handling and maintaining records for quality ­related events, such as for complaints, ADE/MedWatch reporting, recalls, deviations, and investigations.

About this record

Extracted automatically from the document US FDA published on 2019-07-12. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

The Pet Apothecary LLC company profile — full history US FDA documents, 2019 Go to Findings search